Radiotherapy was widely used to combat cancer.

Access to life saving radiotherapy is limited or non existent in many areas.

About 90 out of every 100 people (90 ) with T1 glottic cancers are cured with radiotherapy or surgery alone.

The goal is to establish clinical benefit of the immunotherapy (i.e.,adjuvanted vaccine) over the standard of care, not over standard of care plus adjuvant.

The precise treatment intent (curative, adjuvant, neoadjuvant, therapeutic, or palliative) will depend on the tumor type, location, and stage, as well as the general health of the patient.

Radiation therapy Radiation therapy (also called radiotherapy, X ray therapy, or irradiation) is the use of ionizing radiation to kill cancer cells and shrink tumors.

Radiation Radiotherapy is used when drug treatment is failing to control the pain of a growing tumor, such as in bone metastisis (most commonly), penetration of soft tissue, or compression of sensory nerves.

Additionally, 192Ir is used as a source of gamma radiation for the treatment of cancer using brachytherapy, a form of radiotherapy where a sealed radioactive source is placed inside or next to the area requiring treatment.

Seminoma As an adjuvant treatment, use of chemotherapy as an alternative to radiation therapy in the treatment of seminoma is increasing, because radiation therapy appears to have more significant long term side effects (for example, internal scarring, increased risks of secondary malignancies, etc.).

Radiation therapy Radiation may be used to treat stage 2 seminoma cancers, or as adjuvant (preventative) therapy in the case of stage 1 seminomas, to minimize the likelihood that tiny, non detectable tumors exist and will spread (in the inguinal and para aortic lymph nodes).

Even a relatively small amount of material such as cobalt 60 used in radiotherapy could cause serious harm if combined with conventional explosives in a so called dirty bomb (or otherwise deliberately used to expose the public to dangerous radiation).

We have substantially stepped up our Internet presence, we have revitalized our public seminar programme, and we have conducted a series of media campaigns on important topics, including nuclear security, radiotherapy, nuclear power and earlier this month the Chernobyl Forum report.

By way of comparison, consider that in Austria, where the Agency is headquartered, we have approximately one radiotherapy machine for every 270,000 people whereas for most African countries the ratio is about one machine for every 10 million people, and some countries have no such facilities at all.